Catasys (CATS) Reaches New 52-Week High and Low at $7.64

Catasys, Inc. (NASDAQ:CATS) shares hit a new 52-week high and low during trading on Thursday . The company traded as low as $7.64 and last traded at $7.75, with a volume of 1272 shares changing hands. The stock had previously closed at $7.39.

A number of research analysts recently commented on the stock. ValuEngine upgraded shares of Catasys from a “hold” rating to a “buy” rating in a research note on Friday, June 1st. Zacks Investment Research lowered shares of Catasys from a “hold” rating to a “strong sell” rating in a research note on Friday, April 20th.

The company has a market cap of $113.46 million, a P/E ratio of -8.85 and a beta of 0.32.

Catasys (NASDAQ:CATS) last announced its quarterly earnings results on Tuesday, May 15th. The company reported ($0.27) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.26) by ($0.01). Catasys had a net margin of 50.55% and a negative return on equity of 546.50%. The company had revenue of $1.91 million during the quarter, compared to analyst estimates of $3.00 million. analysts expect that Catasys, Inc. will post -0.73 earnings per share for the current year.

An institutional investor recently bought a new position in Catasys stock. Weber Alan W acquired a new stake in Catasys, Inc. (NASDAQ:CATS) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 108,165 shares of the company’s stock, valued at approximately $406,000. Weber Alan W owned 0.68% of Catasys as of its most recent SEC filing. 4.75% of the stock is owned by institutional investors and hedge funds.

Catasys Company Profile

Catasys, Inc provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services.

Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with's FREE daily email newsletter.

Leave a Reply